Paula Biedermann
Biographic Data
| ID | 7938020 |
|---|---|
| NAME | Paula Biedermann |
| GIVEN NAMES | Paula |
| FAMILY NAME | Biedermann |
| SIGNATURE | BIEDERMANN P |
| AFFILIATIONS | Robert Koch Institute |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2020 |
| H-INDEX | 0 |
Rituximab-Containing Treatment Regimens May Imply a Long-Term Risk for Difficult-To-Treat Chronic Hepatitis E
Hepatitis E virus (HEV) infection is an emerging disease in industrialized countries which is usually characterized by a self-limited course. However, there is an increased risk of HEV persistence in immunocompromised risk populations, comprising patients following solid organ transplantation or hematological malignancies. Recently, chronic HEV infection following rituximab-containing treatment regimens has been described. Here we report five pat…
No prominent works on this page.
Rituximab-Containing Treatment Regimens May Imply a Long-Term Risk for Difficult-To-Treat Chronic Hepatitis E
Hepatitis E virus (HEV) infection is an emerging disease in industrialized countries which is usually characterized by a self-limited course. However, there is an increased risk of HEV persistence in immunocompromised risk populations, comprising patients following solid organ transplantation or hematological malignancies. Recently, chronic HEV infection following rituximab-containing treatment regimens has been described. Here we report five pat…
Antibody (1 work) · Hepatitis B Virus Studies (1 work) · Hepatitis C virus (1 work) · Hepatitis Viruses Studies and Epidemiology (1 work) · Hypogammaglobulinemia (1 work) · Immunology (1 work) · Internal Medicine (1 work) · Liver Disease and Transplantation (1 work) · Medicine (1 work) · Ribavirin (1 work)